iPSC Derived Cell Therapies for Cancer

Cell therapies derived from induced Pluripotent Stem Cell (iPSC) technology is emerging in cancer therapeutics. For example, iPSCs allow the development of immune therapies and drug screening programs in the genetic background of the patient. Discover the latest research on iPSC derived cell therapies for cancer here.

January 19, 2022

Kinase inhibitor-induced cardiotoxicity assessed in vitro with human pluripotent stem cell derived cardiomyocytes.

Toxicology and Applied Pharmacology
Hai-Qing XianH Ralph Snodgrass
January 12, 2022

Proximity labeling identifies a repertoire of site-specific R-loop modulators.

Nature Communications
Qingqing YanKavitha Sarma
January 6, 2022
Review

Advances in NK cell production.

Cellular & Molecular Immunology
Fang FangZhigang Tian
January 6, 2022

Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.

In Vitro Cellular & Developmental Biology. Animal
Fumitaka ObayashiTetsuji Okamoto
January 6, 2022
Open Access

The impact of SBF2 on taxane-induced peripheral neuropathy.

PLoS Genetics
Geneva M CunninghamBryan P Schneider
January 2, 2022
Preprint
Open Access

Transplantation of IPSC-Derived Cardiomyocyte Patches for Ischemic Cardiomyopathy

MedRxiv : the Preprint Server for Health Sciences
Shigeru MiyagawaY. Sawa
December 31, 2021

Stem cells and organs-on-chips: new promising technologies for human infertility treatment.

Endocrine Reviews
Eisa Tahmasbpour MarzouniElena Jane Tucker
December 30, 2021

Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis.

Cell Reports
Nur YucerClive N Svendsen
December 22, 2021

Transcriptional co-activators YAP1-TAZ of Hippo signalling in doxorubicin-induced cardiomyopathy.

ESC Heart Failure
Tünde BereczGabor Foldes
December 19, 2021
Review

Cell reprogramming in liver with potential clinical correlations.

Journal of Digestive Diseases
Yi Chuan WangBei Fang Ning
December 19, 2021

Human-Induced Pluripotent Stem Cell-Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases.

Advances in Experimental Medicine and Biology
Erkan Kiris

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Brain Stem Neoplasms

Brain Stem Neoplasms are cancers that are common in children and can occur in the mesencephalon, pons or medulla oblongata. Discover the latest research on Brain Stem Neoplasms here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

© 2022 Meta ULC. All rights reserved
/feed-previews/ipsc-derived-cell-therapies-for/b4ce42ee-0240-4764-ad4b-9fb5c8a47d5b